Skip to content

Clinical trials

Phase 2 Squamous Intraepithelial Lesions trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Intraepithelial Lesions Phase: Phase 2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20075
20152
20171
20182
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AIDS Malignancy Consortium3
The Center for Clinical and Cosmetic Research2
Tigris Pharmaceuticals2
Gynecologic Oncology Group1
Inovio Pharmaceuticals1
National Cancer Institute (NCI)1
Sirnaomics1
Stephen E. Goldstone1
THEVAX Genetics Vaccine1
University of Alabama at Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Intraepithelial Lesions16
Uterine Cervical Dysplasia5
Anus Neoplasms3
Atypical Squamous Cells of the Cervix3
Precancerous Conditions3
Carcinoma, Squamous Cell2
Papillomavirus Infections2
Skin Neoplasms2
Uterine Cervical Neoplasms2
Bowen's Disease1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.